Enlivex Therapeutics Statistics
Total Valuation
ENLV has a market cap or net worth of $27.27 million. The enterprise value is $3.53 million.
Important Dates
The last earnings date was Friday, November 29, 2024, after market close.
| Earnings Date | Nov 29, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ENLV has 21.99 million shares outstanding. The number of shares has increased by 5.43% in one year.
| Current Share Class | 21.99M |
| Shares Outstanding | 21.99M |
| Shares Change (YoY) | +5.43% |
| Shares Change (QoQ) | +8.87% |
| Owned by Insiders (%) | 5.61% |
| Owned by Institutions (%) | 3.63% |
| Float | 16.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.03 |
| P/TBV Ratio | 1.03 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.71, with a Debt / Equity ratio of 0.03.
| Current Ratio | 9.71 |
| Quick Ratio | 9.28 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -57.93% and return on invested capital (ROIC) is -28.57%.
| Return on Equity (ROE) | -57.93% |
| Return on Assets (ROA) | -26.30% |
| Return on Capital (ROIC) | -28.57% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$266,662 |
| Employee Count | 71 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -22.01% in the last 52 weeks. The beta is 1.01, so ENLV's price volatility has been similar to the market average.
| Beta (5Y) | 1.01 |
| 52-Week Price Change | -22.01% |
| 50-Day Moving Average | 1.27 |
| 200-Day Moving Average | 1.67 |
| Relative Strength Index (RSI) | 53.08 |
| Average Volume (20 Days) | 434,651 |
Short Selling Information
| Short Interest | 214,766 |
| Short Previous Month | 99,233 |
| Short % of Shares Out | 0.49% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.56 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -16.15M |
| Pretax Income | -25.99M |
| Net Income | -18.93M |
| EBITDA | -15.44M |
| EBIT | -16.15M |
| Earnings Per Share (EPS) | -$0.97 |
Full Income StatementBalance Sheet
The company has $24.51 million in cash and $765,000 in debt, giving a net cash position of $23.74 million or $1.08 per share.
| Cash & Cash Equivalents | 24.51M |
| Total Debt | 765,000 |
| Net Cash | 23.74M |
| Net Cash Per Share | $1.08 |
| Equity (Book Value) | 26.59M |
| Book Value Per Share | 1.21 |
| Working Capital | 24.32M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$14.20 million and capital expenditures -$75,000, giving a free cash flow of -$14.28 million.
| Operating Cash Flow | -14.20M |
| Capital Expenditures | -75,000 |
| Free Cash Flow | -14.28M |
| FCF Per Share | -$0.65 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |